Italia markets open in 1 hour 42 minutes

JNJ Jul 2024 150.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,74000,0000 (0,00%)
In data: 03:54PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,7400
Aperto1,8900
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio150,00
Scadenza2024-07-19
Min-Max giorno1,7200 - 2,0100
Contratto - Min-MaxN/D
Volume54
Open InterestN/D
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA